Skip to main content
Erschienen in: Pediatric Radiology 9/2019

19.04.2019 | Original Article

Clinico-radiologic features of pleuroparenchymal fibroelastosis in children

verfasst von: HaiThuy N. Nguyen, Shailendra Das, Maria C. Gazzaneo, Ernestina Melicoff, George B. Mallory, Karen W. Eldin, R. Paul Guillerman

Erschienen in: Pediatric Radiology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Pleuroparenchymal fibroelastosis (PPFE) may be underdiagnosed clinically and radiographically in children with a remote history of cancer, leading to a delay in care and unnecessary lung biopsies.

Objective

To describe the characteristic clinical and radiologic findings of PPFE in a cohort of children to facilitate recognition and noninvasive diagnosis.

Materials and methods

Clinical presentation, history of chemotherapy or radiation therapy, lung or bone marrow transplantation, and lung function testing and outcome were retrospectively extracted from the electronic medical records of eight children treated at our institution’s pulmonary medicine clinic with histopathology confirmation of PPFE from 2008 to 2018. Two pediatric radiologists evaluated the chest imaging studies for the presence or absence of published radiologic findings of PPFE in adults, including platythorax, pneumothorax, upper lobe predominant pleural and septal thickening, and bronchiectasis. Platythorax indices were calculated from the normal chest CT exams of eight age- and gender-matched individuals obtained via the radiology search engine.

Results

The mean presentation age was 12.9 years (range: 7–16 years). Seven of the eight had a history of chemotherapy and radiation therapy for cancer. Three of the eight had undergone bone marrow transplantation and none had undergone lung transplantation. The mean time between chemotherapy, radiation therapy, and/or bone marrow transplantation and the presentation of PPFE was 8.4 years (range: 5.6–12.1 years). Most of the patients presented with dyspnea (63%), cough (50%) and/or pneumothorax (38%). The mean percentage of predicted FEV1 (forced expiratory volume in one second) was 14.1 (range: 7.7–27.5). All eight patients demonstrated platythorax, bronchiectasis, pleural and septal thickening (upper lobes in four, upper and lower lobes in four) and six had pneumothorax. Five underwent lung biopsies, four of whom developed pneumothoraces.

Conclusion

Clinical and radiologic findings of pediatric PPFE are similar to those in adults, although a majority of the former have a history of treated cancer. Clinical presentation of restrictive lung disease, dyspnea, cough or spontaneous pneumothorax years after treatment for childhood cancer combined with platythorax, upper lobe pleural and septal thickening and traction bronchiectasis on chest CT establishes a presumptive diagnosis of PPFE.
Literatur
1.
Zurück zum Zitat Amitani R, Niimi A, Kuze F (1992) Idiopathic pulmonary upper lobe fibrosis (IPUF). Kokyu 11:693–699 Amitani R, Niimi A, Kuze F (1992) Idiopathic pulmonary upper lobe fibrosis (IPUF). Kokyu 11:693–699
2.
Zurück zum Zitat Frankel SK, Cool CD, Lynch DA, Brown KK (2004) Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 126:2007–2013CrossRefPubMed Frankel SK, Cool CD, Lynch DA, Brown KK (2004) Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 126:2007–2013CrossRefPubMed
3.
Zurück zum Zitat Cheng SK, Chuah KL (2016) Pleuroparenchymal fibroelastosis of the lung: a review. Arch Pathol Lab Med 140:849–853CrossRefPubMed Cheng SK, Chuah KL (2016) Pleuroparenchymal fibroelastosis of the lung: a review. Arch Pathol Lab Med 140:849–853CrossRefPubMed
4.
Zurück zum Zitat Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733–748CrossRefPubMedPubMedCentral Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733–748CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Nakatani T, Arai T, Kitaichi M et al (2015) Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity? Eur Respir J 45:1183–1186CrossRefPubMed Nakatani T, Arai T, Kitaichi M et al (2015) Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity? Eur Respir J 45:1183–1186CrossRefPubMed
6.
Zurück zum Zitat Rosenbaum JN, Butt YM, Johnson KA et al (2015) Pleuroparenchymal fibroelastosis: a pattern of chronic lung injury. Hum Pathol 46:137–146CrossRefPubMed Rosenbaum JN, Butt YM, Johnson KA et al (2015) Pleuroparenchymal fibroelastosis: a pattern of chronic lung injury. Hum Pathol 46:137–146CrossRefPubMed
7.
Zurück zum Zitat Reddy TL, Tominaga M, Hansell DM et al (2012) Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J 40:377–385CrossRefPubMed Reddy TL, Tominaga M, Hansell DM et al (2012) Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J 40:377–385CrossRefPubMed
8.
Zurück zum Zitat von der Thüsen JH, Hansell DM, Tominaga M et al (2011) Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol 24:1633–1639CrossRefPubMed von der Thüsen JH, Hansell DM, Tominaga M et al (2011) Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol 24:1633–1639CrossRefPubMed
9.
Zurück zum Zitat Beynat-Mouterde C, Beltramo G, Lezmi G et al (2014) Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents. Eur Respir J 44:523–527CrossRefPubMed Beynat-Mouterde C, Beltramo G, Lezmi G et al (2014) Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents. Eur Respir J 44:523–527CrossRefPubMed
10.
Zurück zum Zitat Camus P, von der Thusen J, Hansell DM, Colby TV (2014) Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs? Eur Respir J 44:289–296CrossRefPubMed Camus P, von der Thusen J, Hansell DM, Colby TV (2014) Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs? Eur Respir J 44:289–296CrossRefPubMed
11.
Zurück zum Zitat Mariani F, Gatti B, Rocca A et al (2016) Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients. Diagn Interv Radiol 22:400–406CrossRefPubMedPubMedCentral Mariani F, Gatti B, Rocca A et al (2016) Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients. Diagn Interv Radiol 22:400–406CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968CrossRef Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968CrossRef
14.
Zurück zum Zitat Dietz AC, Chen Y, Yasui Y et al (2016) Risk and impact of pulmonary complications in survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer 122:3687–3696CrossRefPubMedPubMedCentral Dietz AC, Chen Y, Yasui Y et al (2016) Risk and impact of pulmonary complications in survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer 122:3687–3696CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Griese M, Rampf U, Hofmann D et al (2000) Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 30:393–401CrossRefPubMed Griese M, Rampf U, Hofmann D et al (2000) Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 30:393–401CrossRefPubMed
16.
17.
Zurück zum Zitat Venkatramani R, Kamath S, Wong K et al (2013) Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys 86:942–948CrossRefPubMed Venkatramani R, Kamath S, Wong K et al (2013) Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys 86:942–948CrossRefPubMed
18.
Zurück zum Zitat Williams JP, Johnston CJ, Finkelstein JN (2010) Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets 11:1386–1394CrossRefPubMedPubMedCentral Williams JP, Johnston CJ, Finkelstein JN (2010) Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets 11:1386–1394CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Stone A, Novetsky Friedman D, Worgall S et al (2017) Long-term pulmonary outcomes in pediatric survivors of high-risk neuroblastoma. J Pediatr Hematol Oncol 39:547–554CrossRefPubMedPubMedCentral Stone A, Novetsky Friedman D, Worgall S et al (2017) Long-term pulmonary outcomes in pediatric survivors of high-risk neuroblastoma. J Pediatr Hematol Oncol 39:547–554CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hirota T, Yoshida Y, Kitasato Y et al (2015) Histological evolution of pleuroparenchymal fibroelastosis. Histopathology 66:545–554CrossRefPubMed Hirota T, Yoshida Y, Kitasato Y et al (2015) Histological evolution of pleuroparenchymal fibroelastosis. Histopathology 66:545–554CrossRefPubMed
21.
Zurück zum Zitat Becker CD, Gil J, Padilla ML (2008) Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod Pathol 21:784–787CrossRefPubMed Becker CD, Gil J, Padilla ML (2008) Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod Pathol 21:784–787CrossRefPubMed
22.
Zurück zum Zitat Boland GW, Gazelle GS, Girard MJ, Mueller PR (1998) Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions. AJR Am J Roentgenol 170:943–946CrossRefPubMed Boland GW, Gazelle GS, Girard MJ, Mueller PR (1998) Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions. AJR Am J Roentgenol 170:943–946CrossRefPubMed
23.
Zurück zum Zitat Sugino K, Shimizu H, Nakamura Y et al (2018) Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis. J Thorac Dis 10:899–908CrossRefPubMedPubMedCentral Sugino K, Shimizu H, Nakamura Y et al (2018) Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis. J Thorac Dis 10:899–908CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Boerner EB, Costabel U, Wessendorf TE et al (2017) Idiopathic pleuroparenchymal fibroelastosis (PPFE) – a case study of a rare entity. Rev Port Pneumol 23:352–355PubMed Boerner EB, Costabel U, Wessendorf TE et al (2017) Idiopathic pleuroparenchymal fibroelastosis (PPFE) – a case study of a rare entity. Rev Port Pneumol 23:352–355PubMed
25.
Zurück zum Zitat Sato S, Hanibuchi M, Takahashi M et al (2016) A patient with idiopathic pleuroparenchymal fibroelastosis showing a sustained pulmonary function due to treatment with pirfenidone. Intern Med 55:497–501CrossRefPubMed Sato S, Hanibuchi M, Takahashi M et al (2016) A patient with idiopathic pleuroparenchymal fibroelastosis showing a sustained pulmonary function due to treatment with pirfenidone. Intern Med 55:497–501CrossRefPubMed
26.
Metadaten
Titel
Clinico-radiologic features of pleuroparenchymal fibroelastosis in children
verfasst von
HaiThuy N. Nguyen
Shailendra Das
Maria C. Gazzaneo
Ernestina Melicoff
George B. Mallory
Karen W. Eldin
R. Paul Guillerman
Publikationsdatum
19.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 9/2019
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-019-04405-5

Weitere Artikel der Ausgabe 9/2019

Pediatric Radiology 9/2019 Zur Ausgabe

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.